Table 1.
The chi-square test of the relationship between risk score and clinical features in TCGA cohort
| Clinical feature | Risk Score | c2 | P | |
|---|---|---|---|---|
| High risk n(%) | Low risk n(%) | |||
| Age | 0.931 | 0.335 | ||
| >65 | 59 (46.46%) | 68 (53.54%) | ||
| ≤ 65 | 112 (51.85%) | 104 (48.15%) | ||
| BMI | 1.275 | 0.259 | ||
| >25 | 71 (46.41%) | 82 (53.59%) | ||
| ≤ 25 | 86 (52.76%) | 77 (47.24%) | ||
| Family cancer history | 0.149 | 0.7 | ||
| NO | 29 (23.58%) | 94 (76.42%) | ||
| YES | 19 (26.03%) | 54 (73.97%) | ||
| Gender | 2.032 | 0.154 | ||
| female | 61 (55.45%) | 49 (44.55%) | ||
| male | 110 (47.21%) | 123 (52.79%) | ||
| Tumor status | 10.08931 | 0.001 | ||
| tumor free | 73 (40.78%) | 106 (59.22%) | ||
| with tumor | 87 (58.39%) | 62 (41.61%) | ||
| New tumor event | 4.85 | 0.028 | ||
| no | 71 (43.83%) | 91 (56.17%) | ||
| yes | 94 (55.95%) | 74 (44.05%) | ||
| Prior Malignancy | 2.815 | 0.093 | ||
| no | 160 (51.28%) | 152 (48.72%) | ||
| yes | 11 (35.48%) | 20 (64.52%) | ||
| Histologic Grade | 14.724 | <0.001 | ||
| G1–2 | 90 (42.06%) | 124 (57.94%) | ||
| G3–4 | 79 (63.71%) | 45 (36.29%) | ||
| Stage | 13.911 | <0.001 | ||
| I-II | 104 (43.70%) | 134 (56.30%) | ||
| III-IV | 56 (67.47%) | 27 (32.53%) | ||
| Vascular tumor | 9.806 | 0.002 | ||
| none | 76 (38.38%) | 122 (61.62%) | ||
| Micro-Macro | 58 (57.43%) | 43 (42.57%) | ||
| Race | 0.003 | 0.96 | ||
| white | 86 (50.89%) | 83 (49.11%) | ||
| asian-blank&Indian | 83 (50.61%) | 81 (49.39%) | ||